2025-08-11 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS) based on the provided data.

**Hims & Hers Health Inc (HIMS) Analysis**

**0) Summary Numbers & Initial Analysis**

*   **Ticker:** HIMS
*   **Company:** Hims & Hers Health Inc.
*   **Company Overview:** A telehealth company offering personalized health and wellness solutions.

**1) Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 181.19%
*   **VOO Cumulative Return:** 69.38%
*   **Absolute Divergence (HIMS - VOO):** 111.8%
*   **Relative Divergence:** 53.6% (Indicates HIMS is currently in the upper half of its historical divergence range compared to VOO).

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) over the period. The relative divergence suggests that, while still positive, HIMS's outperformance is not at its historical peak, indicating that the degree of outperformance is at the 53.6 percentile level of the historical data.

**Alpha, Beta Analysis:**

| Year        | CAGR    | MDD   | Alpha | Beta | Cap(B) |
| ----------- | ------- | ----- | ----- | ---- | ------ |
| 2019-2021   | -46.0%  | 51.0% | -85.0% | 0.1  | 1.5    |
| 2020-2022   | -15.0%  | 72.1% | -21.0% | 0.0  | 1.4    |
| 2021-2023   | -51.0%  | 72.1% | -71.0% | -0.2 | 2.0    |
| 2022-2024   | 127.0%  | 78.4% | 100.0% | -0.3 | 5.5    |
| 2023-2025   | 176.0%  | 78.4% | 127.0% | -0.2 | 11.7   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate varies significantly, showing periods of substantial decline followed by periods of strong growth. The recent CAGR (2023-2025) is very high.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant price volatility.
*   **Alpha:** Alpha values have been fluctuating between negative and positive, suggesting that HIMS's performance relative to its benchmark changes over time. The recent Alpha values are strongly positive, indicating outperformance.
*   **Beta:** Beta values are relatively high and show an increasing trend, suggesting that HIMS is more volatile than the market and highly sensitive to market movements.
*   **Cap:** Market capitalization has increased, suggesting some growth in recent years.

**2) Recent Price Action**

*   **Last Price:** $51.94
*   **Previous Close:** $51.05
*   **Change:** 1.74%
*   **5-Day Moving Average:** 54.598
*   **20-Day Moving Average:** 55.5755
*   **60-Day Moving Average:** 54.434

**Analysis:** The stock price is slightly above the previous close, showing a small increase. However, the current price is below all three moving averages (5-day, 20-day, and 60-day), suggesting a potential short-term downward trend. Given the {'price': 51.94, 'previousClose': 51.05, 'change': 1.74} indicates a recent price increase, suggesting a rebound attempt. However, the position below moving averages suggests caution.

**3) Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3323 (Low Risk)
*   **RSI:** 55.77 (Neutral, neither overbought nor oversold)
*   **PPO:** -1.6863 (Negative, suggests a potential downward trend)
*   **Hybrid Signal:** cash\_70% Sell 0.4% of holdings (5 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** -23.1 (Negative, indicates a recent decrease in relative performance compared to the benchmark)
*   **Expected Return:** -17.3% (Indicates an expected underperformance compared to the S&P 500 over the long term if investing from the current point).

**Analysis:** The MRI indicates low market risk. The RSI is neutral. The negative PPO and negative change in relative divergence suggest a recent period of underperformance. The hybrid signal recommends reducing holdings with caution, aligning with the indicators suggesting potential short-term downside. The negative expected return suggests a cautious approach to long-term investment at the current price level.

**4) Recent News & Significant Events**

*   **2025-08-09:** HIMS made headlines due to business developments, regulatory changes, or market events.
*   **2025-08-08:** Analysts discussing HIMS's recent performance and outlook.
*   **2025-08-11:** HIMS stock showing notable volatility.
*   **2025-08-07:** Market experts highlighting both risks and opportunities.

**Analysis:** Recent news indicates increased attention on HIMS due to business developments, regulatory changes, and market events. Analyst discussions and highlighted volatility suggest that the stock's future is uncertain and subject to market sentiment and company-specific announcements. Investors should closely monitor news and company announcements to make informed decisions.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출     |
| ---------- | ---- | -------- |
| 2025-08-04 | 0.19 | 0.54 B\$ |
| 2025-05-05 | 0.22 | 0.59 B\$ |
| 2024-11-04 | 0.35 | 0.40 B\$ |
| 2024-08-05 | 0.06 | 0.32 B\$ |
| 2025-08-04 | 0.06 | 0.32 B\$ |

**Analysis:**

*   **EPS:** EPS (Earnings Per Share) has fluctuated over the past few quarters.
*   **Revenue:** Revenue generally shows an increasing trend over the period.

**6) Financial Information: Revenue and Profitability**

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-06-30   | \$0.54B   | 76.39%        |
| 2025-03-31   | \$0.59B   | 73.50%        |
| 2024-12-31   | \$0.48B   | 76.81%        |
| 2024-09-30   | \$0.40B   | 79.16%        |
| 2024-06-30   | \$0.32B   | 81.30%        |

**Capital and Profitability**

| Quarter      | Equity    | ROE    |
| ------------ | --------- | ------ |
| 2025-06-30   | \$0.56B   | 7.55%  |
| 2025-03-31   | \$0.55B   | 9.01%  |
| 2024-12-31   | \$0.48B   | 5.46%  |
| 2024-09-30   | \$0.44B   | 17.18% |
| 2024-06-30   | \$0.36B   | 3.67%  |

**Analysis:**

*   **Revenue:** Revenue shows a consistent increasing trend over the analyzed quarters, indicating growth in the company's sales.
*   **Profit Margin:** The profit margins are consistently high, suggesting efficient cost management and strong pricing power. However, there is a slight decline in the recent quarter.
*   **Equity:** Equity has increased, which could signify improved financial health.
*   **ROE:** ROE (Return on Equity) shows variability, suggesting that the company's profitability relative to shareholders' equity fluctuates.

**7) 종합 Analysis**

Hims & Hers Health Inc (HIMS) has shown strong revenue growth and high profitability, but the stock is currently facing short-term headwinds. While HIMS has significantly outperformed the S&P 500 historically, recent indicators suggest a period of underperformance. The technical indicators and hybrid signal suggest caution, advising a reduction in holdings. Recent news points to increased volatility and uncertainty surrounding the stock. Overall, HIMS appears to have solid fundamentals, but investors should closely monitor short-term trends and news to make informed decisions. The negative expected return suggests a cautious approach, particularly for long-term investments initiated at the current price.
